Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study-Reference-Cited by-同舟云学术

Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study

Published:2023-09-05 Issue: Volume: Page:1-10
ISSN:1350-6129
Container-title:Amyloid
language:en
Short-container-title:Amyloid

Author:

Aimo Alberto¹²,Teresi Lucio¹³,Castiglione Vincenzo¹²,Picerni Anna Lisa²,Niccolai Martina²,Severino Silvia²,Agazio Assunta²,Carnevale Baraglia Anna⁴,Obici Laura⁴,Palladini Giovanni⁴,Ponti Lucia⁵⁶,Argirò Alessia⁵⁶,Cappelli Francesco⁵⁶^ORCID,Perfetto Federico⁵⁶,Serenelli Matteo⁷,Trimarchi Giancarlo³,Licordari Roberto³,Di Bella Gianluca³,Chubuchna Olena¹,Quattrone Filippo¹,Nuti Sabina⁸,De Rosis Sabina⁸,Passino Claudio¹²,Rapezzi Claudio⁷⁹,Merlini Giampaolo⁴,Emdin Michele¹²^ORCID,Vergaro Giuseppe¹²

Affiliation:

1. Interdisciplinary Center for Health Sciences, Scuola Superiore Sant’Anna, Pisa, Italy

2. Cardiology Division, Fondazione Toscana Gabriele Monasterio, Pisa, Italy

3. Cardiology Division, University Hospital of Messina, Messina, Italy

4. Centro per lo Studio e la Cura delle Amiloidosi Sistemiche, Fondazione Policlinico San Matteo, Pavia, Italy

5. Regional Amyloid Center, Azienda Ospedaliero Universitaria Careggi, Florence, Italy

6. Department of Internal and Experimental Medicine, University of Florence, Florence, Italy

7. Cardiology Centre, University of Ferrara, Italy

8. Management and Healthcare Laboratory, Institute of Management, Scuola Superiore Sant’Anna, Pisa, Italy

9. Maria Cecilia Hospital, GVM Care and Research, Cotignola (Ravenna), Italy

Funder

Pfizer

Publisher

Informa UK Limited

Subject

Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13506129.2023.2254451

Reference19 articles.

1. A simple echocardiographic score to rule out cardiac amyloidosis

2. Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings

3. Burden of hereditary transthyretin amyloidosis on quality of life

4. Treatment of cardiac transthyretin amyloidosis: an update

5. Strategies to improve the quality of life in patients with hereditary transthyretin amyloidosis (hATTR) and autonomic neuropathy